Range Biotechnologies provides an end-to-end solution focused on translational proteomics research. The company develops advanced platforms to analyze protein expression and function relevant to human health applications. This work aims to establish new standards for high-throughput proteomics data generation and interpretation.
Funding
$5.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
AVFounders
Product
Problem
Current methods for protein analysis in translational proteomics lack the accuracy and scalability needed for effective precision medicine, hindering advancements in diagnostics and drug development. Existing biomarker discovery techniques often fall short in providing the quantitative data required for real-world applications.
Solution
Range Biotechnologies offers an end-to-end platform for translational proteomics, enabling accurate and scalable protein quantification to improve diagnostics and accelerate drug development. The company's technology measures protein biomarker panels at scale, uncovering longitudinal dynamics of human health for proactive healthcare. By re-engineering protein detection methods, Range Bio addresses limitations in throughput, multiplexing, and dynamic range, providing researchers with the tools needed for uncompromising protein quantification. The platform facilitates the transition from biomarker discovery to real-world applications, empowering pharmaceutical companies, consumer health organizations, and clinical labs to gain deeper insights into disease mechanisms and therapeutic responses.
Target Audience
Range Biotechnologies primarily serves pharmaceutical companies, consumer health organizations, and clinical labs seeking advanced tools for protein quantification and personalized medicine applications.
Features
- High-throughput multiplexed protein quantification for precision health
- Innovative translational platform to enable better diagnostics and faster drug development
- Technology allows for accurate quantification of multiple proteins across many samples simultaneously
- Provides critical insights into the underlying mechanisms of disease and how they change over time
- Enables a uniquely comprehensive view of an individual’s health and allowing for personalized options for treatments and diagnostics